• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1500300-33
Device Problems Stretched (1601); Device Damaged by Another Device (2915); Difficult to Advance (2920); Material Deformation (2976)
Patient Problem Vascular Dissection (3160)
Event Date 12/04/2018
Event Type  Injury  
Event Description
It was reported through a research article that patient presented with anterior st-elevation myocardial infarction with chest pain.During the percutaneous coronary intervention, a 3.0 x 33 mm xience sierra stent was implanted in the left anterior descending artery (lad), with the proximal stent struts protruding into the ostium of the circumflex artery.Several days later, during a staged procedure to the obtuse marginal (om) artery, a 2.5 x 38 mm xience sierra stent attempted to cross the recently implanted stent in the lad, but resistance was felt, so the 2.5 x 38 mm xience sierra stent system was retracted, but dislodged and was entangled with the lad stent.Both stents became stretched.A snare was used to remove the om stent, but because it was entangled with the lad stent, removal of the om stent resulted in removal of the lad stent and dissections in the lad and distal left main.The arteries were re-wired and new stents were successfully implanted.Results were excellent.Please see article (case 2) for additional information.
 
Manufacturer Narrative
Date of event estimated.Implant and explant dates estimated the device was not returned for analysis.A review of the lot history record and similar incident query for this product were not performed because the lot number was not reported and the product was not returned for analysis.The reported patient effect of dissection is listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure as it is likely the implanted stent interacted with the advancing stent causing the reported difficulty to cross the implanted stent.During retraction continued interaction caused the reported stent stretching, material deformation and complete removal of the implanted stent (explanted) with the patient effect of dissection.The reported treatment appears to be related to operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional xience sierra device referenced is filed under a separate medwatch report number.Literature attachment.Article title ¿case series of iatrogenic coronary stent avulsion: a rare complication with varied management strategies.¿ (case 2).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P031)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13626132
MDR Text Key287562030
Report Number2024168-2022-02079
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUK
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 02/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1500300-33
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
2.5 MM X 38 MM XIENCE SIERRA
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient SexMale
-
-